Company / Interest Expense
KIORA PHARMACEUTICALS INC Interest Expense History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$4.2K
FY2021
5-year range
$325 / $4.2K
FY2017-FY2021
Trend
+1188.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense changed +1188% YoY in FY2021, a notable deviation from the 5-year average annual change of +269%.
Based on SEC 10-K filings.
$4,186 in FY2021 with a 5-year CAGR of -70.7%.
Increased from $1,040 to $4,186 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +51.0%
- 5-Year CAGR
- -70.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -70.7%, indicating a declining trend.
- In FY2021, interest expense increased 1188.0% year-over-year.
- Peak interest expense was recorded in FY2016.
- Lowest interest expense in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2021 | $4.2K | +1188.0% |
| FY2020 | $325 | -68.8% |
| FY2019 | $1.0K | -14.4% |
| FY2018 | $1.2K | +341.8% |
| FY2017 | $275 | -100.0% |
| FY2016 | $1.9M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026